J. Folkman, K. Watson, D. Ingber, and D. Hanahan, Induction of angiogenesis during the transition from hyperplasia to neoplasia, Nature, vol.339, issue.6219, pp.58-61, 1989.
DOI : 10.1038/339058a0

G. Furstenberger, R. Von-moos, R. Lucas, B. Thurlimann, H. Senn et al., Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer, British Journal of Cancer, vol.105, issue.4
DOI : 10.1016/j.canlet.2003.09.018

D. Hicklin and L. Ellis, Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis, Journal of Clinical Oncology, vol.23, issue.5, pp.1011-1027, 2005.
DOI : 10.1200/JCO.2005.06.081

L. Bourhis, X. Romon, R. Hondermarck, and H. , Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications, Breast Cancer Research and Treatment, vol.26, issue.1, pp.17-24, 2010.
DOI : 10.1007/s10549-009-0686-5

URL : https://hal.archives-ouvertes.fr/hal-00535425

K. Kim, B. Li, J. Winer, M. Armanini, N. Gillett et al., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, vol.362, issue.6423, pp.841-844, 1993.
DOI : 10.1038/362841a0

G. Gasparini, Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer, The Oncologist, vol.5, issue.90001, pp.37-44, 2000.
DOI : 10.1634/theoncologist.5-suppl_1-37

D. George, S. Halabi, T. Shepard, N. Vogelzang, D. Hayes et al., Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480, Clin Cancer Res, vol.7, pp.1932-1936, 2001.

J. Lee, N. Chow, S. Wang, and S. Huang, Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients, European Journal of Cancer, vol.36, issue.6, pp.748-753, 2000.
DOI : 10.1016/S0959-8049(00)00003-4

N. Cheung, M. Wong, S. Yuen, S. Leung, and L. Chung, Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon, Human Pathology, vol.29, issue.9, pp.910-914, 1998.
DOI : 10.1016/S0046-8177(98)90195-2

B. Linderholm, B. Tavelin, K. Grankvist, and R. Henriksson, Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma., Journal of Clinical Oncology, vol.16, issue.9, pp.3121-3128, 1998.
DOI : 10.1200/JCO.1998.16.9.3121

M. Stimpfl, D. Tong, B. Fasching, E. Schuster, A. Obermair et al., Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer, Clin Cancer Res, vol.8, pp.2253-2259, 2002.

A. Caporali and C. Emanueli, Cardiovascular Actions of Neurotrophins, Physiological Reviews, vol.89, issue.1, pp.279-308, 2009.
DOI : 10.1152/physrev.00007.2008

L. Reichardt, Neurotrophin-regulated signalling pathways, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.20, issue.5, pp.1545-1564, 2006.
DOI : 10.1128/MCB.20.5.1507-1514.2000

G. Cantarella, L. Lempereur, M. Presta, D. Ribatti, G. Lombardo et al., Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo, The FASEB Journal, vol.16, pp.1307-1309, 2002.
DOI : 10.1096/fj.01-1000fje

C. Emanueli, M. Salis, A. Pinna, G. Graiani, L. Manni et al., Nerve Growth Factor Promotes Angiogenesis and Arteriogenesis in Ischemic Hindlimbs, Circulation, vol.106, issue.17, pp.2257-2262, 2002.
DOI : 10.1161/01.CIR.0000033971.56802.C5

K. Seo, J. Choi, M. Park, and C. Rhee, Angiogenesis effects of nerve growth factor (NGF) on rat corneas, J Vet Sci, vol.2, pp.125-130, 2001.

L. Mcgregor, B. Mccune, J. Graff, P. Mcdowell, K. Romans et al., Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression, Proceedings of the National Academy of Sciences, vol.96, issue.8, pp.4540-4545, 1999.
DOI : 10.1073/pnas.96.8.4540

A. Ricci, S. Greco, S. Mariotta, L. Felici, E. Bronzetti et al., Neurotrophins and Neurotrophin Receptors in Human Lung Cancer, American Journal of Respiratory Cell and Molecular Biology, vol.25, issue.4, pp.439-446, 2001.
DOI : 10.1165/ajrcmb.25.4.4470

Z. Zhu, H. Friess, F. Dimola, A. Zimmermann, H. Graber et al., Nerve Growth Factor Expression Correlates With Perineural Invasion and Pain in Human Pancreatic Cancer, Journal of Clinical Oncology, vol.17, issue.8, pp.2419-2428, 1999.
DOI : 10.1200/JCO.1999.17.8.2419

A. Weeraratna, J. Arnold, D. George, A. Demarzo, and J. Isaacs, Rational basis for Trk inhibition therapy for prostate cancer, The Prostate, vol.51, issue.2, pp.140-148, 2000.
DOI : 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

S. Descamps, V. Pawlowski, F. Revillion, L. Hornez, M. Hebbar et al., Expression of nerve growth factor receptors and their prognostic value in human breast cancer, Cancer Res, vol.61, pp.4337-4340, 2001.

L. Dolle, E. Yazidi-belkoura, I. Adriaenssens, E. Nurcombe, V. Hondermarck et al., Nerve growth factor overexpression and autocrine loop in breast cancer cells, Oncogene, vol.22, issue.36, pp.5592-5601, 2003.
DOI : 10.1038/sj.onc.1206805

L. Dolle, E. Adriaenssens, E. Yazidi-belkoura, I. , L. Bourhis et al., Nerve Growth Factor Receptors and Signaling in Breast Cancer, Current Cancer Drug Targets, vol.4, issue.6, pp.463-470, 2004.
DOI : 10.2174/1568009043332853

E. Adriaenssens, E. Vanhecke, P. Saule, A. Mougel, A. Page et al., Nerve Growth Factor Is a Potential Therapeutic Target in Breast Cancer, Cancer Research, vol.68, issue.2, pp.346-351, 2008.
DOI : 10.1158/0008-5472.CAN-07-1183

C. Lagadec, S. Meignan, E. Adriaenssens, B. Foveau, E. Vanhecke et al., TrkA overexpression enhances growth and metastasis of breast cancer cells, Oncogene, vol.17, issue.18, pp.1960-1970, 2009.
DOI : 10.1038/onc.2009.61

B. Davidson, R. Reich, P. Lazarovici, J. Nesland, M. Skrede et al., Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma, Clin Cancer Res, vol.9, pp.2248-2259, 2003.

M. Park, H. Kwak, H. Lee, D. Yoo, I. Park et al., Nerve Growth Factor Induces Endothelial Cell Invasion and Cord Formation by Promoting Matrix Metalloproteinase-2 Expression through the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway and AP-2 Transcription Factor, Journal of Biological Chemistry, vol.282, issue.42, pp.30485-30496, 2007.
DOI : 10.1074/jbc.M701081200

Z. Liu, K. Kobayashi, M. Van-dinther, S. Van-heiningen, G. Valdimarsdottir et al., VEGF and inhibitors of TGF?? type-I receptor kinase synergistically promote blood-vessel formation by inducing ??5-integrin expression, Journal of Cell Science, vol.122, issue.18, pp.3294-3302, 2009.
DOI : 10.1242/jcs.048942

K. Sugimoto, S. Fujii, T. Takemasa, and K. Yamashita, Detection of intracellular nitric oxide using a combination of aldehyde fixatives with 4,5- diaminofluorescein diacetate, Histochem Cell Biol, vol.113, pp.341-347, 2000.

S. Dimmeler, E. Dernbach, and A. Zeiher, Phosphorylation of the endothelial nitric oxide synthase at Ser-1177 is required for VEGF-induced endothelial cell migration, FEBS Letters, vol.32, issue.3, pp.258-262, 2000.
DOI : 10.1016/S0014-5793(00)01657-4

T. Murohara, B. Witzenbichler, I. Spyridopoulos, T. Asahara, B. Ding et al., Role of Endothelial Nitric Oxide Synthase in Endothelial Cell Migration, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.5, pp.1156-1161, 1999.
DOI : 10.1161/01.ATV.19.5.1156

X. Campos, Y. Munoz, A. Selman, R. Yazigi, L. Moyano et al., Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer, Gynecologic Oncology, vol.104, issue.1, pp.168-175, 2007.
DOI : 10.1016/j.ygyno.2006.07.007

N. Ferrara, H. Gerber, and J. Lecouter, The biology of VEGF and its receptors, Nature Medicine, vol.9, issue.6, pp.669-676, 2003.
DOI : 10.1038/nm0603-669

S. Javerzat, A. P. Bikfalvi, and A. , The role of fibroblast growth factors in vascular development, Trends in Molecular Medicine, vol.8, issue.10, pp.483-489, 2002.
DOI : 10.1016/S1471-4914(02)02394-8

U. Rahbek, S. Dissing, C. Thomassen, A. Hansen, and K. Tritsaris, Nerve growth factor activates aorta endothelial cells causing PI3K/Akt- and ERK-dependent migration, Pfl??gers Archiv - European Journal of Physiology, vol.269, issue.5, pp.355-361, 2005.
DOI : 10.1007/s00424-005-1436-0

J. Steinle and H. Granger, Nerve growth factor regulates human choroidal, but not retinal, endothelial cell migration and proliferation, Autonomic Neuroscience, vol.108, issue.1-2, pp.57-62, 2003.
DOI : 10.1016/S1566-0702(03)00151-6

H. Dvorak, J. Nagy, D. Feng, L. Brown, and A. Dvorak, Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis, Curr Top Microbiol Immunol, vol.237, pp.97-132, 1999.
DOI : 10.1007/978-3-642-59953-8_6

J. Nagy, D. Feng, E. Vasile, W. Wong, S. Shih et al., Permeability properties of tumor surrogate blood vessels induced by VEGF-A, Laboratory Investigation, vol.52, pp.767-780, 2006.
DOI : 10.1083/jcb.145.6.1189

D. Fukumura and R. Jain, Role of nitric oxide in angiogenesis and microcirculation in tumors, Cancer and Metastasis Reviews, vol.17, issue.1, pp.77-89, 1998.
DOI : 10.1023/A:1005908805527

S. Kashiwagi, Y. Izumi, T. Gohongi, Z. Demou, L. Xu et al., NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels, Journal of Clinical Investigation, vol.115, issue.7, pp.1816-1827, 2005.
DOI : 10.1172/JCI24015DS1

F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, I. Sardi et al., Cyclooxygenase-2 Activation Mediates the Proangiogenic Effect of Nitric Oxide in Colorectal Cancer, Clinical Cancer Research, vol.10, issue.8, pp.2694-2704, 2004.
DOI : 10.1158/1078-0432.CCR-03-0192

S. Namkoong, S. Lee, C. Kim, Y. Kim, H. Chung et al., Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells, Experimental & Molecular Medicine, vol.37, issue.6, pp.588-600, 2005.
DOI : 10.1038/emm.2005.72

S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse et al., Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation, Nature, vol.399, pp.601-605, 1999.

M. Salis, G. Graiani, E. Desortes, R. Caldwell, P. Madeddu et al., Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice, Diabetologia, vol.47, issue.6, pp.1055-1063, 2004.
DOI : 10.1007/s00125-004-1424-5

L. Calza, L. Giardino, A. Giuliani, L. Aloe, and R. Levi-montalcini, Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors, Proceedings of the National Academy of Sciences, vol.98, issue.7, pp.4160-4165, 2001.
DOI : 10.1073/pnas.051626998

N. Hansen-algenstaedt, P. Algenstaedt, C. Schaefer, A. Hamann, L. Wolfram et al., Neural driven angiogenesis by overexpression of nerve growth factor, Histochemistry and Cell Biology, vol.45, issue.Suppl. 3, pp.637-649, 2006.
DOI : 10.1007/s00418-005-0111-z

P. Gaur, D. Bose, S. Samuel, and L. Ellis, Targeting Tumor Angiogenesis, Seminars in Oncology, vol.36, pp.12-19, 2009.
DOI : 10.1053/j.seminoncol.2009.02.002